COVID-19 update

10th Nov 2020

The RDTC has updated the COVID-19 QAAs No.4 (Monitoring direct acting oral anticoagulants) with more detail on monitoring and the recent MHRA Drug Safety Update on DOACs and bleeding risk. QAA No.6 (Alternatives to hydroxycobalamin injection) has been updated to include information on newly UK licensed product (Orobalin). Please see the RDTC COVID-19 Information and resources page.